Hemodilution has had limited success as a treatment of cerebral ischemia. When using a nonoxygen binding fluid, the therapeutic efficacy of hemodilution induced increases in CBF are offset by concomitant de creases in oxygen content. The effect of hemodilution, with diaspirin a-a cross-linked hemoglobin (DCLHb), on CBF during middle cerebral artery occlusion was as sessed. Rats were hemodiluted to one of the following hematocrits (Hct): (a) 44/Hct, (b) 37/Hct, (c) 30/Hct, (d) 23/Hct, (e) 16/Hct, or (D 9IHct. After 10 min of ischemia, CBF was determined with 14C-iodoantipyrine. Coronal brain sections were evaluated for areas with a CBF of 0-10 and 11-20 ml 100 g-I min -I. In addition, oxygen delivery was calculated. In the center of the ischemic Abbreviations used: DCLHb, diaspirin a-a cross-linked hemo globin; Hct, hematocrit; MABP, mean arterial blood pressure; MCAO, middle cerebral artery occlusion .
Hemodilution, via an increase in CBF, has been advocated as a treatment of focal cerebral ischemia (Heros and Korosue, 1989) . However, the results of hemodilution studies have been inconsistent (Wood et aI., 1983; Tu et aI., 1988; Italian Acute Stroke Study Group, 1988; Scandinavian Stroke Study Group, 1988; Hemodilution in Stroke Study Group, 1989; Asplund, 1989; Koller et aI., 1990; Cole et aI., 1990a) . Although there may be many explanations for this inconsistency (e.g., treatment delay, mag nitude of hematocrit reduction, associated side ef fects [Cole et aI., 1990b; Cole et aI., 1990c] ), one proposal is an inherent limitation of oxygen delivery that is imposed when using nonoxygen-binding flu-zone, both areas of low CBF were less in the 30/Hct, 23/Hct, and 16/Hct groups compared with the 44/Hct and 37/Hct groups; and both areas were less in the 9/Hct group compared with the other five groups (p < 0.05). For the hemisphere contralateral to occlusion, there was a direct correlation between hematocrit and oxygen deliv ery. However, for the hemisphere ipsilateral to occlusion, oxygen delivery increased as hematocrit decreased (441 Hct, 8.6 ± 0.3 vs. 9/Hct, 13.6 ± 0.4 [mean ± SD, ml 100 g-I min -1]). The results of this study support a hypoth esis that hemodilution with DCLHb decreases the extent of focal cerebral ischemia. Key Words: Focal cerebral ischemia-Hemodilution-Hemoglobin. ids for hemodilution. In such a scenario, any in crease in oxygen delivery effected by hemodilution induced increases in CBF would be limited or nul lified by an associated decrease in oxygen-carrying capacity.
Although controversial and not satisfactorially studied in the brain, in terms of oxygen delivery to ischemic brain, it has been suggested that the opti mal hematocrit (Hct) when hemodiluting with a nonoxygen-binding fluid is 30--35% (Kee and Wood, 1987) . It is postulated that if the Hct is <30%, al though CBF continues to increase, absolute oxygen delivery is reduced secondary to decreased oxygen carrying capacity. We evaluated the dose-related effect of hemodilution with a stroma-free diaspirin a-a cross-linked hemoglobin solution (DCLHb) on CBF, after 10 min of middle cerebral artery occlu sion (MCAO) in rats.
MATERIALS AND METHODS
The hemoglobin solution was prepared according to ChatteIjee et al. (1986) . In brief, outdated human red blood cells were lysed by exposure to hypertonic buffer. The hemolysate was centrifuged to separate and remove stroma lipids. After ultrafiltration, molecular hemoglobin was cross-linked at the a chain by reaction with the di aspirin compound, bis(3,5-dibromosalicyl) fumarate. Elimination of viral contamination and protein purifica tion was achieved by heat pasteurization (Estep et aI., 1989a; Estep et aI., 1989b) . The DCLHb was diluted to a concentration of -10 g dl-1 by adding electrolyte and buffer solutions. The lot release analysis is presented in Table 1 . The DCLHb solution was stored at -70°C until needed for the current study at which time it was thawed to 5°C, and on the day of the study passively warmed to room temperature and diluted to 7 g dl-1 with lactated Ringer's to match whole blood oncotic pressure (-25 mm Hg). Oxygen transport of DCLHb is similar to whole blood (Chatterjee et aI., 1986) with a slight increase in oxygen unloading due to a right-shift in the oxygen dis sociation curve (Vandergriff et aI., 1989 [ Table 1 ]). The a-a cross-linking with bis(3,5 dibromosalicyl) fumarate stabilizes the hemoglobin tetramer and prolongs intravas cular retention (Hess et aI., 1989) . The viscosity of DCLHb was 1.3 centistokes, which is comparable to se rum albumin (Usami et aI., 1971) and considerably less than that of whole blood (>4.0 centistokes [DeVenuto et aI., 1981] ).
After approval by the Animal Research Committee of Lorna Linda University, male, spontaneously hyperten sive rats (350--400 g, 16--20 weeks) were anesthetized (1.44% isoflurane), orotracheally intubated, and mechan ically ventilated with a Harvard rodent respirator (Har vard, Boston, MA, U.S.A.). The left femoral artery was cannulated for continuous blood pressure monitoring (Full Scale TransducerlT A 2000 Recorder [Gould, Cerri tos, CA, U.S.A.]) and blood sampling. The right femoral vein was cannulated for isotope and fluid administration. Maintenance fluids (0.9% NaCl) were infused at a rate of 4 ml kg -1 h -I . Cranial temperature was servo-controlled at 37°C with a heating blanket. Each rat was randomized to one of the following hypervolemic-hemodilution groups (blood volume increased by 8.0 ml and hematocrit maintained at steady state for at least 30 min): 44/Hct (n = 9). Blood volume was increased by giving 8.0 ml of donor blood (Hct not manipulated); 37IHct (n = 9). Blood volume and Hct (37%) were manipulated by giving 8.0 ml of DCLHb (Baxter Healthcare Corporation, Deerfield IL, U.S.A. [Lot 2905T008]); 30IHct (n = 9). Blood volume and Hct (30%) were manipulated by a 5.0-ml exchange transfusion with DCLHb, and an additional 8.0 ml of DCLHb; 23/Hct (n = 9). Blood volume and Hct (23%) were manipulated by a 1O.0-ml exchange transfusion with DCLHb, and an additional 8.0 ml of DCLHb; 16/Hct (n = 9). Blood volume and Hct (16%) were manipulated by a 15.0-ml exchange transfusion with DCLHb, and an addi tional 8.0 ml of DCLHb; 9IHct (n = 9). Blood volume and Hct (9%) were manipulated by a 20.0-ml exchange trans fusion with DCLHb, and an additional 8.0 ml of DCLHb.
Part A
Via a subtemporal craniectomy, MCAO was achieved with 10-0 monofilament nylon suture, in two locations (proximal to the lenticulostriate branch and distal to the inferior cerebral vein) to achieve consistent ischemia to both cortical and subcortical tissue (Cole et aI., 1990a; Cole et aI., 1990b After 10 min of MCAO, 100 J.LCi kg -1 of 14C_ iodoantipyrine (New England Nuclear, Boston, MA, U.S.A.) was given at a constantly increasing rate over 46 s. Twenty one arterial blood samples were collected for determination of 14C activity with a quench correction (Beckman 8000 Liquid Scintillation Spectrometer [Beck man, Brea, CA, U.S.A.]). After the 14C was infused, the brains were removed in <60 s and placed in 2-methylbu tane ( -35°C). The brains were sectioned in 20-J.Lm incre ments, and 10 sections surrounding each of five anatom ically predetermined coronal planes were placed on x-ray film (Kodak OM-I, Rochester, NY, U.S.A.) for 21 days. The five anatomical planes were in 2.0-mm sequential increments and spanned middle cerebral artery distribu tion. Section 1 was at the anterior midline extent of the corpus callosum, and Section 5 was 1.0 mm posterior to the posterior midline extent of the corpus callosum (see Cole et aI., 1992 , for a figure of the five sections).
After film processing, assessment of CBF was done with a computer program based on the equation of Sakurada et al. (1978) . A tissue-blood partition coeffi cient of 0.80 was used, and each autoradiograph cali brated to nine 14C standards (Amersham, Arlington Heights, IL, U.S.A.). By use of a DrexeUDUMAS Image Analysis System (Drexel University, Philadelphia, PA, U.S.A.) each anatomical section was analyzed to define areas with a CBF of 0-10 and 11-20 ml 100 g-I min -I. In addition, in Section 3, absolute CBF was determined for each hemisphere; and by use of the oxygen content data from Part B, oxygen delivery was calculated (oxygen de livery = oxygen content x CBF). All image analysis was performed by an independent observer who was blinded to study protocol.
Part B
With the exception of a craniotomy, different sponta neously hypertensive rats were prepared identically to Part A (n = 6 for each group). With the use of an IL-282
Co-oximeter (Instrumentation Laboratory, Lexington, MA, U.S.A.), and at the appropriate hemodilution end point, arterial blood was collected and analyzed for he- matocrit, total hemoglobin, and oxygen content accord ing to the method described by Dennis and Valeri (1980) . The data were compared by analysis of variance with mUltiple linear regression analysis. As indicated, mean values were compared by t tests with a Bonferroni cor rection for multiple comparisons (Wilkinson, 1987) . A p value of less than 0.05 was considered significant.
RESULTS
All values are reported as mean ± SD. Except for expected differences in hematocrit, there were no between-group differences in the physiologic data (Table 2) .
Part A
Area with a CBF of 0-1 0 ml 100 g-I min-I.
There was no difference between the 44/Hct and 37/Hct groups. However, for the other four groups, this CBF area was less as hematocrit decreased (Ta ble 3). For example, in Section 2 the area (% of the hemisphere ipsilateral to MCAO) with a CBF of 0-10 was 31.7 ± 5. 1 and 30.8 ± 5.9 in the 44/Hct and 37/Hct groups, respectively; versus 21.4 ± 4.9, 20.2 ± 6.4, and 21.9 ± 5.9 in the 30/Hct, 23/Hct, and 16/Hct groups (p < 0.05); versus 10.6 ± 4.2 in the 9/Hct group (p < 0.05).
Area with a CBF of 11-20 ml 100 g -I min -I.
There was no difference between the 44/Hct and 37/Hct groups. However, for the other four groups, this area of low CBF was less as hematocrit de creased (Table 3) . For example, in Section 2 the area with a CBF of II -20 ml 100 g -I min -I was 28.4 ± 5.4 and 27.2 ± 3.7 in the 44/Hct and 37/Hct groups, respectively; versus 20.5 ± 4. 1, 20.8 ± 3.9, and 21.7 ± 4.9 in the 30/Hct, 23/Hct, and 16/Hct groups, respectively (p < 0.05); versus 14.2 ± 4.3 in the 9/Hct group (p < 0.05).
Absolute CBF. In both hemispheres there was a progressive increase in CBF as hematocrit de creased (Table 4 ). 11.1 ± 3.4 12.5 ± 6.5 11.0 ± 3.1 11.0 ± 3.7 11.1 ± 4.5 10.9 ± 3.3 a p < 0.05 versus the other five groups. b p < 0.05 versus the 44/Hct, 37/Hct, 30/Hct, and 23/Hct groups. c p < 0.05 versus the 44/Hct and 37/Hct groups.
Part B
There were expected between-group differences in hematocrit, total hemoglobin, and oxygen con tent (Table 5 ).
DISCUSSION
The results of this study indicate that hemodilu tion with DCLHb effects a dose-related decrease in the areas of low CBP during MCAO in rats. When oxygen delivery was calculated for the ischemic hemisphere, decreasing hematocrit from 44 to 9% with DCLHb effects a >50% increase in calculated oxygen delivery. In addition, in "normal" brain (hemisphere contralateral to MCAO) there was a dose-related increase in CBP as hematocrit de creased. However, when oxygen delivery was cal culated for this hemisphere, hemodilution effected a decrease in oxygen delivery.
Two mechanisms have been postulated as effect ing the increase in CBP observed during hemodilu tion. The relative contribution of each mechanism may depend upon whether normal or ischemic brain is being evaluated. During nonischemic conditions, both mechanisms are likely to be active. The first mechanism by which hemodilution increases CBP is by decreasing blood viscosity (Paulson et aI., 1973; Haggendal et aI., 1966; Haggendal and Nor back, 1966) while the second is a direct vasodilatory response due to decreased oxygen content and de livery to the brain (Back and von Kummer, 199 1; von Kummer et aI., 1988; Brown et aI., 1985) . Al though the second mechanism may be meaningful in normal brain, where myogenic and neurogenic CBP responses are active, it is plausible that the isch emic vasculature responds differently.
In an ischemic vasculature, areas of low flow, stasis, and vasoparalysis are present (Hartmann et aI., 1989; Symon et aI., 1977) . With low flow and shear rates, decreasing viscosity is expected to ef fect a greater increase in CBP than in normal brain (Harrison, 1989) . In such areas, viscosity-induced enhancement of microvascular flow velocity effects a greater increase in tissue oxygenation than in nor mal tissue (Mirhashemi et aI., 1987) . In addition, it is difficult to conceive that, in areas of dense isch emia with profound vasodilation and vasoparalysis, reductions in oxygen content would induce further vasodilation. Recent data have demonstrated de creased vascular reactivity to hemodilution-induced reductions in oxygen content during impaired cere bral perfusion (Back and von Kummer, 199 1). Other investigators have reported findings which are consistent with viscosity as the predominant mechanism of hemodilution-induced increases in CBP during ischemia (Korosue and Heros, 1992; Hartmann et aI., 199 1; Muizelaar et aI., 1986) . How ever, to our knowledge there have been no studies which have definitively resolved this controversy, and it was not within the scope of this study to do so.
A critique of this study may be the lack of a nor movolemic 44/Hct group. If such a group were in cluded we may have been able to distinguish meth odologically the effects of hypervolemia to those of hemodilution. However, as hypervolemia per se does not increase CBP [despite an increase in car diac output (Wood et aI., 1982) ], we did not feel a seventh group was necessary. A second critique may be the choice of CBP ranges. Most autoradio graphic analyses of local CBP have measured flow in specific anatomic structures or areas. We chose to measure the area of two ischemic CBP ranges (0--10 and 11-20 ml 100 g-I min -I), which were based on an overview of the available data regard ing the correlation between specific CBP ranges and neuronal survival or function (Hakim, 1987; Ty son et aI., 1984; Astrup et aI., 198 1; Symon et aI., 1977) . We acknowledge that the specific CBP ranges chosen may not strictly apply to all clinical or experimental circumstances of cerebral isch emia; however, it is unlikely that the application of a different set of CBP ranges to the present study would have changed the conclusions. And finally, we did not measure microcirculatory hemoglobin in the brain. Accordingly, the oxygen delivery data are not likely to be quantitatively absolute, but rather in proportion to, and an indicator of, cerebral oxygen transport capacity (Scharf et aI., 1989) .
The employment of hemodilution as a therapeutic tool in the treatment of focal cerebral ischemia has produced inconsistent results. This apparent incon sistency may be related to at least three issues. The first concerns the possibility there is a transitory interval following the onset of ischemia in which therapeutic maneuvers that augment CBP are effec-22.6 ± OH 22.5 ± 0.5C 21.5 ± 0.5b 20.0 ± 0.5a
11.3 ± O.4C 11.7 ± 0.3c 11.5 ± O.4c 13.6 ± 0.4" tive in limiting injury (Hemodilution in Stroke Study Group, 1989 ). If therapy is instituted follow ing a meaningful delay, the injury may have pro gressed past the point where therapy is effective. In contrast, if hemodilution is instituted before or shortly after the onset of ischemia, a positive out come may be more likely. In the present study, he modilution was instituted prior to ischemia, limiting the relevance of this model to circumstances in which hemodilution is employed prophylactically during situations that convey a predictable risk of focal cerebral ischemia (e.g., carotid endarterec tomy, occlusion of a cerebral artery during aneu rysm surgery). The second issue concerns potential adjunctive effects of hypervolemia. When hyper volemia and hemodilution are concurrently em ployed, hypervolemia may counter decreases in perfusion pressure that are associated with iso volemic hemodilution (Scandinavian Stroke Study Group, 1988; Tu et aI., 1988) . In addition, hyper volemia may be therapeutic for dehydration and hy povolemia, which have recently been implicated as occurring with frequency in a subpopulation of stroke patients, and exacerbating ischemic injury (Goslinga et aI., 1992) .
In conclusion, the effect of hypervolemic he modilution with a hemoglobin solution was deter mined. The results support the hypothesis that he modilution with a-a cross-linked hemoglobin ef fects a decrease in the areas of ischemia (CBP of 0--10 and 11-20 ml 100 g-I min -I) following 10 min of MCAO in rats. Moreover, this decrease in isch emia was dose-related with the least area of isch emia being in the group that was hemodiluted to a hematocrit of 9%. Our study is limited in its con clusions because CBP was measured only once dur ing a short ischemic period (10 min). The therapeu tic benefit of the present treatment modality must be addressed in terms of functional and/or histo logic outcome before a more definitive statement can be made.
